KG Co Gmbh Management Ventures Science Life Tvm V Enanta Pharmaceuticals Inc

As of March 5, 2014


KG Co Gmbh Management Ventures Science Life Tvm V Net Worth

  • Net worth is estimated to be at least $104.45M
  • Owns at least 1,178,534 units of Enanta Pharmaceuticals Inc stock
  • Sold an estimated value of $28.86M in the last year at Enanta Pharmaceuticals Inc

KG Co Gmbh Management Ventures Science Life Tvm V Trading

  • Largest purchase of shares was 2,532,119 units , worth over $1.86M on March 28, 2013
  • Largest sale of shares was 439,334 units , worth over $17.05M on March 5, 2014
  • In total has made about 5 transactions over a year
  • Usually trades in February, with the busiest year in 2014

KG CO GMBH VENTURES SCIENCE LIFE TVM V, KG Co GmbH Management Ventures Science Life TVM V, KG CO GMBH TVM IV, KG Co GmbH Management TVM IV, KG CO GMBH VENTURES MEDICAL TVM, GmbH Capital TVM, Hubert Birner, Stefan Fischer, Alexandra Goll, HELMUT SCHUHSLER

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

KG Co Gmbh Management Ventures Science Life Tvm V Mailing Address

  • Mailing address is 101 Arch Street Suite 1950 Boston MA 02210 MA

Enanta Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 83,344 units sold on April 5, 2022 by Nathalie Adda worth over $5.97M
  • In the last 9 years, insiders at Enanta Pharmaceuticals Inc sold an estimated value of $97.83M and bought an estimated value of $17.97M
  • The most active traders are Paul Mellett, Treasurer and CFO,  Jay Luly, President and CEO,  and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO
  • Insider trading is most common in February, with the busiest year in 2014

ENANTA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1